HilleVax, Inc. (HLVX)
NASDAQ: HLVX · Real-Time Price · USD
1.950
+0.020 (1.04%)
At close: May 2, 2025, 4:00 PM
1.990
+0.040 (2.05%)
After-hours: May 2, 2025, 4:47 PM EDT

HilleVax Statistics

Total Valuation

HilleVax has a market cap or net worth of $96.48 million. The enterprise value is -$50.44 million.

Market Cap 96.48M
Enterprise Value -50.44M

Important Dates

The next estimated earnings date is Monday, May 12, 2025, after market close.

Earnings Date May 12, 2025
Ex-Dividend Date n/a

Share Statistics

HilleVax has 49.22 million shares outstanding. The number of shares has increased by 21.07% in one year.

Current Share Class 49.22M
Shares Outstanding 49.22M
Shares Change (YoY) +21.07%
Shares Change (QoQ) +0.41%
Owned by Insiders (%) 3.76%
Owned by Institutions (%) 52.60%
Float 30.03M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.62
P/TBV Ratio 0.62
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 10.84, with a Debt / Equity ratio of 0.16.

Current Ratio 10.84
Quick Ratio 10.42
Debt / Equity 0.16
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -32.24

Financial Efficiency

Return on equity (ROE) is -70.13% and return on invested capital (ROIC) is -26.97%.

Return on Equity (ROE) -70.13%
Return on Assets (ROA) -24.89%
Return on Invested Capital (ROIC) -26.97%
Return on Capital Employed (ROCE) -60.69%
Revenue Per Employee n/a
Profits Per Employee -$10.52M
Employee Count 14
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -85.62% in the last 52 weeks. The beta is 0.86, so HilleVax's price volatility has been lower than the market average.

Beta (5Y) 0.86
52-Week Price Change -85.62%
50-Day Moving Average 1.71
200-Day Moving Average 1.83
Relative Strength Index (RSI) 70.85
Average Volume (20 Days) 349,614

Short Selling Information

The latest short interest is 1.52 million, so 3.10% of the outstanding shares have been sold short.

Short Interest 1.52M
Short Previous Month 1.59M
Short % of Shares Out 3.10%
Short % of Float 5.07%
Short Ratio (days to cover) 6.10

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -106.96M
Pretax Income -156.27M
Net Income -147.27M
EBITDA -105.08M
EBIT -106.96M
Earnings Per Share (EPS) -$3.00
Full Income Statement

Balance Sheet

The company has $171.43 million in cash and $24.51 million in debt, giving a net cash position of $146.92 million or $2.98 per share.

Cash & Cash Equivalents 171.43M
Total Debt 24.51M
Net Cash 146.92M
Net Cash Per Share $2.98
Equity (Book Value) 154.49M
Book Value Per Share 3.16
Working Capital 161.89M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$108.79 million and capital expenditures -$522,000, giving a free cash flow of -$109.31 million.

Operating Cash Flow -108.79M
Capital Expenditures -522,000
Free Cash Flow -109.31M
FCF Per Share -$2.22
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

HilleVax does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -21.07%
Shareholder Yield -21.07%
Earnings Yield -152.65%
FCF Yield -113.31%

Analyst Forecast

The average price target for HilleVax is $2.33, which is 19.49% higher than the current price. The consensus rating is "Hold".

Price Target $2.33
Price Target Difference 19.49%
Analyst Consensus Hold
Analyst Count 5
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) -17.69%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2